The transcriptional basis of steroid physiology

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 63, Issue , 1998, Pages 577-585

  Lin, R J ^a,b   Kao, H Y ^a,c   Ordentlich, P ^a,d   Evans, R M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c The Leukemia & Lymphoma Society   (United States)

^d Hewlitt Foundation for Medical Research

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; HISTONE DEACETYLASE; RETINOIC ACID; STEROID; STEROID RECEPTOR; BUTYRIC ACID; COREPRESSOR PROTEIN; DNA BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; EPIDERMAL GROWTH FACTOR; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NOTCH RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOID RELATED ORPHAN RECEPTOR ALPHA; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR HES 1; TRICHOSTATIN A;

ACETYLATION; ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; GENE SILENCING; HORMONE ACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; XENOPUS; CARCINOGENICITY; CELL DIFFERENTIATION; COLON CANCER; DNA BINDING; DNA TRANSCRIPTION; ENZYME ACTIVITY; GENE REPRESSION; GRANULOCYTE; HISTONE ACETYLATION; HUMAN; LEUKEMOGENESIS; ONCOGENE; PROMYELOCYTIC LEUKEMIA; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TWO HYBRID SYSTEM;

EID: 0032450902     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1998.63.577     Document Type: Conference Paper

References (57)

1. Alland L., Muhle R., Hou H., Jr., Potes J., Chin L., Schreiber-Agus N., and DePinho R.A. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387: 49.
2. Anzick S.L., Kononen J., Walker R.L, Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., and Meltzer P.S. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancers. Science 277: 965.
3. Bannister A.J. and Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641.
4. Borrow J., Stanton V.P., Jr., Andresen J.M., Becher R., Behm F.G., Chaganti R.S., Civin C.I., Disteche C., Dube I., Frischauf A.M., Horsman D., Mitelman F., Volinia S., Watmore A.E., and Housman D.E. 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14: 33.
5. Bray S. 1998. A Notch affair. Cell 93: 499.
6. Brown D., Kogan S., Lagasse E., Weissman I., Alcalay M., Pelicci P.O., Atwater S., and Bishop J.M. 1997. A PMLRARα transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. 94: 2551.
7. Casanova J., Helmer E., Selmi-Ruby S., Qi J.S., Au-Fliegner M., Desai-Yajnik V., Koudinova N., Yarm F., Raaka B.M., and Samuels H.H. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14: 5756.
8. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Juguilon H., Montminy M., and Evans R.M 1996. Role of CBP/p300 in nuclear receptor signalling. Nature 383: 99.
9. Chen J.D. and Evans R.M. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454.
10. Chen Z., Brand N.J., Chen A., Chen S.J., Tong J.H., Wang Z.Y., Waxman S., and Zelent A. 1993. Fusion between a novel Krüppel-like zinc finger gene and the retinoid acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBO. 12: 1161.
11. Chen Z., Guidez F., Rousselot P., Agadir A., Chen S.J., Wang Z.Y., Degos L., Zelent A., Waxman S., and Chomienne C. 1994. PLZF-RARα fusion proteins generated from the variant t(11;17) (q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild type retinoid acid receptors. Proc. Natl Acad. Sci. 91: 1178.
12. Chomienne C., Fenaux P., and Degos L. 1996. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10: 1025.
13. Damm K., Thompson C.C., and Evans R.M. 1989. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339: 593.
14. de Thé H., Lavau C., Marchi A., Chomienne C., Degos L., and Dejean A. 1991. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675.
15. Ding W., Li W.-P., Nobile L.M., Grills G., Carrera I., Paiett E., Tallman M.S., Wiernik P.H., and Gallagher R.E. 1998. Retinoic acid receptor alpha (RARct)-region mutations in the PML-RARα fusion gene of acute promyelocytic leukemia (APL) patients after relapse from all-trans retinoic acid (ATRA) therapy. Blood 90: 415a.
16. Dong S., Zhu J., Reid A., Strutt P., Guidez F., Zhong H.J., Wang Z.Y., Licht J., Waxman S., Chomienne C., Chen A., Zelent A., and Chen. S.-J. 1996. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-α fusion protein. Proc. Natl. Acad. Sci. 93: 3624.
17. Dou S., Zeng X., and Cortes P. 1994. The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Mol. Cell. Biol. 14: 3310.
18. Felsenfeld G. 1992. Chromatin as an essential part of the transcriptional mechanism. Nature 355: 219.
19. Glass C.K., Rose D.W., and Rosenfeld M.G. 1997. Nuclear receptor coactivators. Curr. Opin. Cell. Biol. 9: 222.
20. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P.P., Donti E., Biondi A., Lo Coco F., Grignani F., and Pelicci P.G. 1994. Acute promyelocytic leukemia: From genetics to treatment. Blood 83: 10.
21. Grignani F., Ferrucci P.F., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Grignani F., Peschle C., Nicoletti I., and Pelicci P.G. 1993. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74: 423.
22. Grisolano J.L., Wesselschmidt R.L., Pelicci P.G., and Ley T.J. 1997. Altered myeloid development and acute leukemias in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood 89: 376.
23. Grunstein M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349.
24. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., and Ayer D.E. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341.
25. He L.-Z., Guidez F., Tribioli C., Peruzzi D., Ruthardt M., Zelent A., and Pandolfi P.P. 1998. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18: 126.
26. He L.-Z., Tribioli C., Rivi R., Peruzzi D., Pelicci P.G., Soareas V., Cattoretti G., and Pandolfi P.P. 1997. Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc. Natl. Acad. Sci. 94: 5302.
27. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., Yang W.M., Brard G., Ngo S.D., Davie J.R., Seto E., Eisenman R.N., Rose D.W., Glass C.K., and Rosenfeld M.G. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43.
28. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., and Rosenfeld M.G. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397.
29. Hsieh J.J.-D. and Hayward S.D. 1995. Masking of the CBF1/RBPjk transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268: 560.
30. Hsieh J.J.-D., Henkel T., Salmon P., Robey E., Peterson M.G., and Hayward D. 1996. Truncated mammalian Notch 1 activated CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr Virus EBNA2. Mol. Cell. Biol. 16: 952.
31. Ida K,. Kitabayashi I., Taki T., Taniwaki M., Noro K., Yamamoto M., Ohki M., and Hayashi Y. 1997. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90: 4699.
32. Imaizumi M., Suzuki H., Yoshinari M., Sato A., Saito T., Sugawara A., Tsuchiya S., Hatae Y., Fujimoto T., Kakizuka A., Konno T., and Iinuma K. 1998. Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood 92: 374.
33. Jansen J.H., Mahfoudi A., Rambaud S., Lavau C., Wahli W., and Dejean A. 1995. Multimeric complexes of the PML-retinoic acid receptor a fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc. Natl. Acad. Sci. 92: 7401.
34. Jarriault S., Brou C., Logeat F., Schroeter E.H., Kopan R., and Israel A. 1995. Signaling downstream of activated mammalian Notch. Nature 377: 355.
35. Kakizuka A., Miller W.H., Jr., Umesono K., Warrell R.P., Frankel S.R., Murty V.V.V.S., Dmitrovsky E., and Evans R.M. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia (APL) fuses the RARα receptor with a novel putative transcription factor PML. Cell 66: 663.
36. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., and Rosenfeld M.G. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403.
37. Kannabiran C., Zeng X. Y., and Vales L.D. 1997. The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression. Mol. Cell. Biol. 17: 1.
38. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., and Eisenman R.N. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89: 349.
39. Licht J.D., Chomienne C., Coy A., Chen A., Scott A.A., Head D.R., Michaux J.L., Wu Y., DeBlasio A., Miller W.H., Jr., Zelentz A.D., Willman C.L., Chen A., Chen S.-J., Zelent A., Macintyre E., Veil A., Cortes J., Kantarjian H., and Waxman S.. 1995. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85: 1083.
40. Miyazawa K., Mon A., Yamamoto K., and Okudaira H. 1998. Transcriptional roles of CCAAT/enhancer binding protein-β, nuclear factor-κB, and C-promoter binding factor 1 in interleukin (IL)-1β-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J. Biol. Chem. 273: 7620.
41. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J.M., Iwama T., and Miyaki M. 1996. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12: 1565.
42. Nagy L., Kao H.-Y., Chakravarti D., Lin R., Hassig C.A., Ayer D.E., Schreiber S.L., and Evans R.M. 1997. Nuclear receptor repression mediated by a complex containing SMRT, Sin3, and histone deacetylase. Cell 89: 373.
43. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953.
44. Plaisance S., Vanden Berghe, W., Boone, E., Fiers, W., and Haegeman, G. 1997. Recombination signal sequence binding protein JK is constitutively bound to the NF-κB site of the Interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell. Biol. 17: 3733.
45. Rousselot P., Hardas B., Patel A., Guidez F., Gaken J., Castaigne S., Dejean A., de Thé H., Degos L., Farzaneh F., and Chomienne C. 1994. The PML-RARα gene product of t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9: 545.
46. Ruthardt M., Testa U., Nervi C., Ferrucci P.F., Grignani F., Puccetti E., Grignani F., Peschle C., and Pelicci P.G. 1997. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor α (RARα) and PLZF-RARα fusion proteins on retinoic acid signaling. Mol. Cell. Biol. 17: 4859.
47. Sap J., Munoz A., Schmitt J., Stunnenberg H., and Vennstrom B. 1989. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 340: 242.
48. Shao W., Benedetti L., Lamph W.W., Nervi C., and Miller W.H. 1997. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation. Blood 89: 4282.
49. Sharif M. and Privalsky M.L. 1991. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell 66: 885.
50. Sternberg P.W., Stern M.J., Clark I., and Herskowitz I. 1987. Activation of the yeast HO gene by release from multiple negative controls. Cell 48: 567.
51. Struhl K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12: 599.
52. Taki T., Sako M., Tsuchida M., and Hayashi Y. 1997. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89: 3945.
53. Taunton J., Hassig C.A., and Schreiber S.L. 1996. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272: 408.
54. Wettstein D.A., Turner D.L., and Kintner C.R. 1997. The Xenopus homolog of Drosophila Suppressor of Hairless mediates Notch signaling during primary neurogenesis. Development 124: 693.
55. Yang X-J., Ogryzko V.V., Nishikawa J., Howard B.H., and Nakatani Y. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319.
56. Yoshida M., Horinouchi S., and Beppu T. 1995. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function. BioEssays 17: 423.
57. Zenke M., Munoz A., Sap J., Vennstrom B., and Beug H. 1990. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61: 1035.